Congestive heart failure is a chronic heart condition that usually occurs in older people However people with a history of ...
ZOLL®, an Asahi Kasei company that manufactures medical devices and related software solutions, will highlight the latest sudden cardiac death research, case experiences for heart failure readmission ...
Morning Overview on MSN
Study: GLP-1 drugs like Ozempic may limit heart damage after attack
Researchers at the University of Bristol have identified a specific biological mechanism by which GLP-1 drugs, the same class ...
Artificial intelligence (AI)-based ECG interpretation outperformed standard pathways for the detection of occlusive ...
A liquid injected into the heart that sets like a gel could one day prevent strokes caused by atrial fibrillation, animal tests suggest.
Sanjay Bhojraj, a cardiologist who has spent 20 years treating heart attacks, shares evening habits that influence heart health. Here are the routines that can improve blood pressure, glucose control, ...
A clotbusting drug commonly used to treat ischemic stroke interacts negatively with a promising anti-inflammatory treatment (anakinra), underscoring the need to test new stroke therapies alongside ...
A clotbusting drug commonly used to treat ischemic stroke interacts negatively with a promising anti-inflammatory treatment (anakinra), underscoring ...
BACKGROUND: Premature atrial contractions (PACs) are independently associated with atrial fibrillation, stroke, and heart failure, yet no pharmacological therapy is approved for PAC suppression.
A new study found that women who went through so-called premature menopause had 40 percent more fatal and nonfatal heart attacks over the course of their lives.
BioCardia ®, Inc. [NASDAQ: BCDA] , a developer of cellular and cell-derived therapeutics for the treatment of cardiovascular and pulmonary diseases, today announced the FDA has accepted its ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results